News Medical 

Dec 22 2019

A new study published in the journal PLOS Medicine shows that the number of prostate cancer deaths could be reduced by a sixth by simply introducing targeted screening, which is directed at detecting cases among men whose genes put them at higher risk of the disease. The study employs computer modelling to evaluate the potential risk-benefit ratio of routinely screening all adult males aged 55-69 years for prostate cancer by a simple blood test every four years, vs only those who have a higher risk. Read More